Nobivac NXT HCP

Authorised

This medicine is authorised for use in the European Union

felid herpesvirus 1, strain G2620A, live / feline calicivirus, strain F9, live / feline panleucopenia virus, strain MW-1, live

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Nobivac NXT HCP
• Active substance:
  • felid herpesvirus 1, strain G2620A, Live
  • feline calicivirus (FCV), strain F9, live
  • feline panleucopenia virus (FPL), strain MW-1, live
• International non-proprietary name (INN) or common name:
  • felid herpesvirus 1, strain G2620A, live
  • feline calicivirus, strain F9, live
  • feline panleucopenia virus, strain MW-1, live

Pharmacotherapeutic group

• Live viral vaccines
• Immunologicals for felidae
• feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus

Authorisation details

• EMA product number:
  EMEA/V/C/006681

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Nobivac NXT HCP

Adopted